We are live on ! Find out more
Schroder Investment Management Group

Schroder Investment Management Group Portfolio holdings

AUM $141B
1-Year Est. Return 34.18%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$99.1B
AUM Growth
-$5.32B
Cap. Flow
-$740M
Cap. Flow %
-0.75%
Top 10 Hldgs %
27.72%
Holding
1,277
New
83
Increased
445
Reduced
587
Closed
91

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$927M
2
AVGO icon
Broadcom
AVGO
+$406M
3
BLK icon
Blackrock
BLK
+$362M
4
CARR icon
Carrier Global
CARR
+$224M
5
LRCX icon
Lam Research
LRCX
+$172M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$325M
2
TSLA icon
Tesla
TSLA
+$304M
3
GEV icon
GE Vernova
GEV
+$283M
4
NVDA icon
NVIDIA
NVDA
+$280M
5
ZBRA icon
Zebra Technologies
ZBRA
+$277M

Sector Composition

Rank Sector Weight
1 Technology 26.33%
2 Financials 13.48%
3 Communication Services 12.67%
4 Consumer Discretionary 12.01%
5 Healthcare 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWQ icon
776
iShares MSCI France ETF
EWQ
$332M
$4.14M ﹤0.01%
102,600
+82,047
+399% +$3.22M
AWK icon
777
American Water Works
AWK
$27.1B
$4.14M ﹤0.01%
28,307
-62,712
-69% -$8.26M
WVE icon
778
Wave Life Sciences
WVE
$1.02B
$4.13M ﹤0.01%
+479,269
New +$5.24M
IYW icon
779
iShares US Technology ETF
IYW
$25.7B
$4.13M ﹤0.01%
29,340
-25,775
-47% -$4.01M
YUMC icon
780
Yum China
YUMC
$16.2B
$4.12M ﹤0.01%
79,433
-22,970
-22% -$1.1M
BCRX icon
781
BioCryst Pharmaceuticals
BCRX
$2.51B
$4.11M ﹤0.01%
522,657
WEC icon
782
WEC Energy
WEC
$35.9B
$4.02M ﹤0.01%
37,368
+3,133
+9% +$320K
KBR icon
783
KBR
KBR
$4.81B
$4M ﹤0.01%
79,478
-7,318
-8% -$390K
VEU icon
784
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
$3.99M ﹤0.01%
65,800
ZYME icon
785
Zymeworks
ZYME
$1.83B
$3.98M ﹤0.01%
321,949
-15,212
-5% -$207K
MAG
786
DELISTED
MAG Silver
MAG
$3.94M ﹤0.01%
251,066
-72,034
-22% -$1.12M
RDY icon
787
Dr. Reddy's Laboratories
RDY
$10.3B
$3.92M ﹤0.01%
297,322
-109,893
-27% -$1.52M
DRI icon
788
Darden Restaurants
DRI
$25.4B
$3.87M ﹤0.01%
18,883
-1,664
-8% -$321K
APGE icon
789
Apogee Therapeutics
APGE
$10.2B
$3.85M ﹤0.01%
96,992
+38,526
+66% +$1.49M
LNC icon
790
Lincoln National
LNC
$8.67B
$3.84M ﹤0.01%
107,733
+9,054
+9% +$321K
JXN icon
791
Jackson Financial
JXN
$9.1B
$3.84M ﹤0.01%
46,178
-36,955
-44% -$3.28M
FINV
792
FinVolution Group
FINV
$1.07B
$3.8M ﹤0.01%
+389,570
New +$3.19M
PFF icon
793
iShares Preferred and Income Securities ETF
PFF
$13.3B
$3.8M ﹤0.01%
123,030
DKS icon
794
Dick's Sporting Goods
DKS
$18.1B
$3.78M ﹤0.01%
18,705
+673
+4% +$150K
XEL icon
795
Xcel Energy
XEL
$49.3B
$3.7M ﹤0.01%
53,093
+4,510
+9% +$307K
KVUE icon
796
Kenvue
KVUE
$36.9B
$3.61M ﹤0.01%
152,386
-7,919
-5% -$175K
TPL icon
797
Texas Pacific Land
TPL
$23.9B
$3.61M ﹤0.01%
8,292
-5,673
-41% -$2.53M
LHX icon
798
L3Harris
LHX
$53.7B
$3.61M ﹤0.01%
17,366
-2,851
-14% -$598K
UAL icon
799
United Airlines
UAL
$41B
$3.59M ﹤0.01%
51,060
-15,515
-23% -$1.47M
GGAL icon
800
Galicia Financial Group
GGAL
$7.23B
$3.58M ﹤0.01%
65,752
+7,368
+13% +$458K

Similar funds

Schroder Investment Management Group's Q1 2025 Portfolio in Review

As of Q1 2025, Schroder Investment Management Group held 1,277 positions worth $99.1B, down 5.1% from $104B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Schroder Investment Management Group's Q1 2025 filing shows 83 new, 445 increased, 587 reduced and 91 closed positions. Its largest new stake was Arista Networks: 9,143,531 shares worth $708M. The largest sale was Merck, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Financials and Communication Services.

  • Schroder Investment Management Group's largest Q1 2025 buy was Arista Networks: 9,143,531 shares worth $708M.
  • Schroder Investment Management Group added most to Broadcom in Q1 2025, an estimated $406M increase.
  • Schroder Investment Management Group's biggest Q1 2025 reduction was Merck, cutting an estimated $325M.
  • Schroder Investment Management Group fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $62M.
  • Schroder Investment Management Group's ten largest holdings make up 28% of its $99.1B portfolio in Q1 2025.
  • Schroder Investment Management Group opened 83 new positions and closed 91 in Q1 2025.
  • Schroder Investment Management Group's portfolio value fell 5.1% quarter-over-quarter to $99.1B.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.